Monoclonal gammopathy of undetermined significance
1,652views
Monoclonal gammopathy of undetermined significance
Hematologic system
Acute radiation syndrome
Anemias
Diamond-Blackfan anemia
Fanconi anemia
Autoimmune hemolytic anemia
Extrinsic hemolytic normocytic anemia: Pathology review
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemolytic disease of the newborn
Hereditary spherocytosis
Intrinsic hemolytic normocytic anemia: Pathology review
Paroxysmal nocturnal hemoglobinuria
Pyruvate kinase deficiency
Sickle cell disease (NORD)
Fanconi anemia
Folate (Vitamin B9) deficiency
Megaloblastic anemia
Vitamin B12 deficiency
Alpha-thalassemia
Anemia of chronic disease
Beta-thalassemia
Iron deficiency anemia
Lead poisoning
Sideroblastic anemia
Microcytic anemia: Pathology review
Anemia of chronic disease
Aplastic anemia
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders
Dysplastic and proliferative disorders
Heme synthesis disorders
Leukemoid reaction
Mixed platelet and coagulation disorders
Plasma cell dyscrasias
Platelet disorders
High Yield Notes
6 pages
Summary
Monoclonal gammopathy of undetermined significance (MGUS), is a condition in which there is a single paraprotein in blood without any evidence of other diseases or abnormal conditions.
MGUS is considered to be a "premalignant" condition and can eventually develop into multiple myeloma or a lymphoproliferative disorder. Treatment for MGUS is generally not necessary, as the condition is generally considered to be benign. However, regular monitoring is important.